GSK says cancer drug effective against more cervical cancer viruses

05/5/2005 | Forbes

GlaxoSmithKline reported its cervical cancer vaccine Cervarix is effective against three more types of the virus that cause the cancer. The news follows GSK's recent announcement it acquired the U.S. firm that produces a key component of the vaccine, a move analysts say brings production in-house and avoids large royalty payments.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Claims Director
PacificSource
Springfield, OR
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA